Chemed Corporation (CHE) Presents at 2026 UBS Global Healthcare Conference Transcript
Chemed Corporation Declares Quarterly Dividend of 70 Cents
Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference
CHE Q3 deep dive: VITAS and Roto-Rooter drive revenue growth, margin headwinds persist
Chemed (CHE) Looks Repriced As Raised Guidance And Margin Gains Lift The Narrative
5 insightful analyst questions from Chemed’s Q3 earnings call
Jefferies Upgrades Chemed to Buy from Hold
Chemed (CHE) Stock Gets Fair Value Bump As Vitas Strength Offsets Roto Concerns
RBC Capital Maintains Sector Perform on Chemed, Raises Price Target to $585
UBS Maintains Buy on Chemed, Raises Price Target to $675
Oppenheimer Maintains Outperform on Chemed, Raises Price Target to $625
What Chemed (CHE) Said on Its Q3 Earnings Call
Chemed: Q3 Earnings Snapshot
Jefferies Upgrades Chemed to Buy, Raises Price Target to $620
LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor Enthusiasm
Chemed (CHE) Q3 2026 Earnings Call Transcript
Jefferies upgrades Chemed to Buy, sees compounder multiple returning on Q3 beat
Chemed Corporation (CHE) Q3 2026 Earnings Call Transcript
Chemed Corporation Q3 2026 Earnings Call Summary
Chemed Q3 2026 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.